mhurhangee/ep-ind-claims huggingface dataset:
A hardware accelerator for a computer system, the hardware accelerator including a programmable device, the hardware accelerator comprising: a static region comprising non-reconfigurable static circuitry; and kernel logic configured in the programmable device, wherein the kernel logic is at least partially reconfigurable, and operation of the kernel logic is configured to be selectively enabled or disabled; and wherein the kernel logic comprises an intellectual property, IP, checker circuit, the IP checker circuit configured to: obtain a device identifier, ID, of the programmable device and a signed whitelist, the signed whitelist including a list of device IDs and a signature; verify the signature of the signed whitelist; compare the device ID against the list of device IDs; and selectively enable or disable the operation of the kernel logic by selectively asserting or deasserting an enable of the kernel logic based on presence or absence, respectively, of the device ID in the list of device IDs and verification of the signature. a static region comprising non-reconfigurable static circuitry; and kernel logic configured in the programmable device, wherein the kernel logic is at least partially reconfigurable, and operation of the kernel logic is configured to be selectively enabled or disabled; and wherein the kernel logic comprises an intellectual property, IP, checker circuit, the IP checker circuit configured to: obtain a device identifier, ID, of the programmable device and a signed whitelist, the signed whitelist including a list of device IDs and a signature; verify the signature of the signed whitelist; compare the device ID against the list of device IDs; and selectively enable or disable the operation of the kernel logic by selectively asserting or deasserting an enable of the kernel logic based on presence or absence, respectively, of the device ID in the list of device IDs and verification of the signature. obtain a device identifier, ID, of the programmable device and a signed whitelist, the signed whitelist including a list of device IDs and a signature; verify the signature of the signed whitelist; compare the device ID against the list of device IDs; and selectively enable or disable the operation of the kernel logic by selectively asserting or deasserting an enable of the kernel logic based on presence or absence, respectively, of the device ID in the list of device IDs and verification of the signature.
A machining unit, in particular a hand-held electric circular saw, preferably a pendulum guard saw, having a base body which in particular comprises a base plate; and having a drive unit which comprises a driven saw blade and which is pivotable about a pivot axis relative to the base body, with the pivot axis extending in parallel with the saw blade plane defined by the saw blade, characterized in that at least one fixing rod (61A, 61B) is provided for selectively fixing the drive unit relative to the base body, with the fixing rod (61A, 61B) being rotatably supported at the drive unit and being displaceably guided along a guidance track at the base body or vice versa.
A halftone phase shift photomask blank comprising a transparent substrate and a halftone phase shift film thereon, said halftone phase shift film consisting of silicon and nitrogen, or silicon, nitrogen and oxygen, providing a transmittance of at least 10% and a phase shift of 150° to 200° relative to light of wavelength up to 200 nm, and having a thickness of up to 70 nm, said halftone phase shift film being a single layer consisting of silicon and nitrogen, or silicon, nitrogen and oxygen, with the content of oxygen being up to 1/3 of the content of nitrogen as expressed in atomic ratio, and having a refractive index of at least 2.4, characterized in that the film has an absorption coefficient of 0.3 to 0.54, or a multilayer film including at least one layer consisting of silicon and nitrogen, or silicon, nitrogen and oxygen, with the content of oxygen being up to 1/3 of the content of nitrogen as expressed in atomic ratio, and having a refractive index of at least 2.4, characterized in that the film has an absorption coefficient of 0.3 to 0.54.
A compound of Formula I or a pharmaceutically acceptable salt thereof, wherein: W, X, Y and Z are each independently selected from CH or N; D and D 1 are independently selected from a bond and NR b; A is unsubstituted quinolinyl; L is a bond, -C -, -(CR c R c) m -, -OC -, -(CR c R c) m -OC -, -(CR c R c) m -C -, -NR b C -, or -NR b C -; R 1 is selected from alkyl, cycloalkyl, aryl, heteroaryl, and heterocyclyl; each of which is substituted with 0-5 occurrences of R d; each R 3 is independently selected from halo, haloalkyl, alkyl, hydroxyl and -OR a; each R a is independently selected from alkyl, acyl, hydroxyalkyl and haloalkyl; each R b is independently selected from hydrogen and alkyl; each R c is independently selected from hydrogen, halo, alkyl, alkoxy and halo alkoxy; each R d is independently selected from halo, haloalkyl, haloalkoxy, alkyl, alkynyl, nitro, cyano, hydroxyl, -C R a, -OC R a, -C OR a, -SR a, -NR a R b and -OR a, or two R d taken together with the carbon atoms to which they are attached form an optionally substituted heterocyclyl; n is 0, 1, or 2; m is 1, 2 or 3; and h is 1 and g is 2, or g is 1 and h is 2. W, X, Y and Z are each independently selected from CH or N; D and D 1 are independently selected from a bond and NR b; A is unsubstituted quinolinyl; L is a bond, -C -, -(CR c R c) m -, -OC -, -(CR c R c) m -OC -, -(CR c R c) m -C -, -NR b C -, or -NR b C -; R 1 is selected from alkyl, cycloalkyl, aryl, heteroaryl, and heterocyclyl; each of which is substituted with 0-5 occurrences of R d; each R 3 is independently selected from halo, haloalkyl, alkyl, hydroxyl and -OR a; each R a is independently selected from alkyl, acyl, hydroxyalkyl and haloalkyl; each R b is independently selected from hydrogen and alkyl; each R c is independently selected from hydrogen, halo, alkyl, alkoxy and halo alkoxy; each R d is independently selected from halo, haloalkyl, haloalkoxy, alkyl, alkynyl, nitro, cyano, hydroxyl, -C R a, -OC R a, -C OR a, -SR a, -NR a R b and -OR a, or two R d taken together with the carbon atoms to which they are attached form an optionally substituted heterocyclyl; n is 0, 1, or 2; m is 1, 2 or 3; and h is 1 and g is 2, or g is 1 and h is 2.
Process for preparing 2,2-difluoroethanol, comprising the following steps: step (i): reacting 1-chloro-2,2-difluoroethane with an alkali metal salt of formic acid or acetic acid in a suitable solvent to give the corresponding 2,2-difluoroethyl formate or 2,2-difluoroethyl acetate, characterized in that 1-chloro-2,2-difluoroethane is added gradually to a mixture, heated to the desired reaction temperature, of solvent and alkali metal salt of formic acid or acetic acid; step (ii): transesterifying the 2,2-difluoroethyl formate or 2,2-difluoroethyl acetate from step (i) in the presence of an alcohol and optionally of a base. step (i): reacting 1-chloro-2,2-difluoroethane with an alkali metal salt of formic acid or acetic acid in a suitable solvent to give the corresponding 2,2-difluoroethyl formate or 2,2-difluoroethyl acetate, characterized in that 1-chloro-2,2-difluoroethane is added gradually to a mixture, heated to the desired reaction temperature, of solvent and alkali metal salt of formic acid or acetic acid; step (ii): transesterifying the 2,2-difluoroethyl formate or 2,2-difluoroethyl acetate from step (i) in the presence of an alcohol and optionally of a base.
A medical device delivery system comprising: a medical device mounted on an elongate member; a delivery sheath surrounding the medical device; and a first activation line and a second activation line positioned between an inner surface of the delivery sheath and an outer surface of the medical device; wherein the delivery sheath is configured to split along a first split line and a second split line to form a first segment and a second segment and to evert the first segment and the second segment inward, when tension is applied to the first activation line and the second application line. a medical device mounted on an elongate member; a delivery sheath surrounding the medical device; and a first activation line and a second activation line positioned between an inner surface of the delivery sheath and an outer surface of the medical device; wherein the delivery sheath is configured to split along a first split line and a second split line to form a first segment and a second segment and to evert the first segment and the second segment inward, when tension is applied to the first activation line and the second application line.
A push-in outlet system suitable for connecting a user to networks, said outlet system comprising an interface and a functional module, said interface being adapted to be arranged between said functional module and a substrate, wherein the interface and the functional module are configured to receive and/or comprise corresponding mating connections (14, 25) arranged in a central and vertical plane in relation to said functional module and said substrate, and said functional module comprising a plurality of outlet connections (29, 30, 31) suitable for being connected with the users equipment, characterized in that said functional module comprises a circuit board arranged inside said functional module wherein said circuit board is adapted to divide and pass through a back connection into said plurality of outlet connections (29, 30, 31).
A system comprising: a computing apparatus comprising a processor and a program memory; and a bus adapter card coupled with the computing apparatus and configured to connect with a storage device, the bus adapter card comprising a cache memory and a controller to cache in the cache memory data associated with the storage device; wherein the program memory includes a host driver to communicate with the bus adapter card responsive to requests corresponding to the storage device; and the host driver is configured to modify its communications with the bus adapter card responsive to information provided separate from the requests, the system is further characterized in that the information comprises a directive associated with the requests corresponding to the storage device, and the host driver is configured to communicate the directive associated with at least one request to the bus adapter card to alter a caching behavior of the bus adapter card, wherein the directive is based at least in part on at least one policy received from a policy engine. a computing apparatus comprising a processor and a program memory; and a bus adapter card coupled with the computing apparatus and configured to connect with a storage device, the bus adapter card comprising a cache memory and a controller to cache in the cache memory data associated with the storage device; wherein the program memory includes a host driver to communicate with the bus adapter card responsive to requests corresponding to the storage device; and the host driver is configured to modify its communications with the bus adapter card responsive to information provided separate from the requests, the system is further characterized in that the information comprises a directive associated with the requests corresponding to the storage device, and the host driver is configured to communicate the directive associated with at least one request to the bus adapter card to alter a caching behavior of the bus adapter card, wherein the directive is based at least in part on at least one policy received from a policy engine.
A frame for an aerosol-generating device, the frame comprising: a base frame formed from an electrically conductive material; an electrical connector having a connector frame and a plurality of electrical contacts (41, 42, 43), the plurality of electrical contacts (41, 42, 43) being arranged on the connector frame, and the connector frame being formed from an electrically insulating material, the electrical connector being secured to the base frame such that the base frame is electrically connected to at least one of the electrical contacts (41, 42, 43) of the electrical connector; and a support frame formed from an electrically insulating material, the base frame and electrical connector being at least partially embedded in the support frame. a base frame formed from an electrically conductive material; an electrical connector having a connector frame and a plurality of electrical contacts (41, 42, 43), the plurality of electrical contacts (41, 42, 43) being arranged on the connector frame, and the connector frame being formed from an electrically insulating material, the electrical connector being secured to the base frame such that the base frame is electrically connected to at least one of the electrical contacts (41, 42, 43) of the electrical connector; and a support frame formed from an electrically insulating material, the base frame and electrical connector being at least partially embedded in the support frame.
A method of regenerating Mg 2 in a process that reduces the amount of CO 2 contained in a gas stream, comprising: (a) reacting MgCl 2 containing material with steam in a first admixture, preferably at a temperature from about 250°C to about 350°C, to form step (a) products comprising Mg Cl, preferably in an amount of greater than 90% by weight, and HCl, where the MgCl 2 containing material comprises a water to MgCl 2 ratio of less than about 2.5:1; (b) reacting Mg Cl with steam in a second admixture, preferably at a temperature from about 350°C to about 500°C, to form step (b) products comprising HCl and magnesium-containing products comprising mostly Mg 2; (c) reacting Mg 2 with CO 2, CaCl 2, and steam, preferably at a temperature from about 140°C to about 220°C, to form step (c) products comprising MgCl 2 and CaCO 3, said step preferably comprising admixing Mg 2 from step (b) with CO 2 contained in the gas stream in a third admixture to form first step (c) products comprising MgCO 3 and H 2 O, and admixing the MgCO 3 from first step (c) products with CaCl 2 in a fourth admixture, preferably with a ratio of water to MgCl 2 of about 4 to 1, to form a second step (c) products comprising CaCO 3 and MgCl 2. (a) reacting MgCl 2 containing material with steam in a first admixture, preferably at a temperature from about 250°C to about 350°C, to form step (a) products comprising Mg Cl, preferably in an amount of greater than 90% by weight, and HCl, where the MgCl 2 containing material comprises a water to MgCl 2 ratio of less than about 2.5:1; (b) reacting Mg Cl with steam in a second admixture, preferably at a temperature from about 350°C to about 500°C, to form step (b) products comprising HCl and magnesium-containing products comprising mostly Mg 2; (c) reacting Mg 2 with CO 2, CaCl 2, and steam, preferably at a temperature from about 140°C to about 220°C, to form step (c) products comprising MgCl 2 and CaCO 3, said step preferably comprising admixing Mg 2 from step (b) with CO 2 contained in the gas stream in a third admixture to form first step (c) products comprising MgCO 3 and H 2 O, and admixing the MgCO 3 from first step (c) products with CaCl 2 in a fourth admixture, preferably with a ratio of water to MgCl 2 of about 4 to 1, to form a second step (c) products comprising CaCO 3 and MgCl 2.
A mirror structure, comprising a mirror having a reflective surface arranged to allow a portion of incident light to pass therethrough and wherein the mirror has at least one component of an optical sensor integrated therewith, arranged to receive light that passes through said reflective surface, and wherein said at least one component of an optical sensor is a Hartmann mask of an optical wavefront sensor and wherein the Hartmann mask comprises an array of apertures integrated into the mirror structure.
A computer-implemented method for generating a medical image, the method comprising: determining a location and an alignment for a first tracking detector with respect to a particle beam system, wherein determining the location and the alignment includes converting local coordinates of a test pattern, consisting of a set of discrete proton spots at which a calibrated steering beam is delivered to the first tracking detector, to coordinates relative to isocenter of the particle beam system to calculate projective transformations from the measured local coordinate system of the first tracking detector to the ideal coordinate system of the plane of the first tracking detector according to a predetermined plan of alignment of the first tracking detector with respect to the particle beam system; determining a first position and a first initial kinetic energy of a first particle generated from the beam system, from a detected particle hit on the first tracking detector; determining a first direction of the first particle at the first tracking detector; determining a first residual range of the first particle from a detected particle hit on a residual range detector; reconstructing a path for the first particle directly in coordinates relative to isocenter of the particle beam system based on the location, the alignment, the projective transformations, the first position, the first direction, and the first initial kinetic energy; and generating the medical image based on the reconstructed path for the first particle and the first residual range and the first initial kinetic energy of the first particle. determining a location and an alignment for a first tracking detector with respect to a particle beam system, wherein determining the location and the alignment includes converting local coordinates of a test pattern, consisting of a set of discrete proton spots at which a calibrated steering beam is delivered to the first tracking detector, to coordinates relative to isocenter of the particle beam system to calculate projective transformations from the measured local coordinate system of the first tracking detector to the ideal coordinate system of the plane of the first tracking detector according to a predetermined plan of alignment of the first tracking detector with respect to the particle beam system; determining a first position and a first initial kinetic energy of a first particle generated from the beam system, from a detected particle hit on the first tracking detector; determining a first direction of the first particle at the first tracking detector; determining a first residual range of the first particle from a detected particle hit on a residual range detector; reconstructing a path for the first particle directly in coordinates relative to isocenter of the particle beam system based on the location, the alignment, the projective transformations, the first position, the first direction, and the first initial kinetic energy; and generating the medical image based on the reconstructed path for the first particle and the first residual range and the first initial kinetic energy of the first particle.
A method for diagnosing or detecting advanced colorectal adenomas in a human subject comprising the steps of: measuring an overall expression pattern or level of one or more microRNAs obtained from one or more biological samples of the subject, wherein at least one of those microRNAs is miR18a; and comparing the overall expression pattern of the one or more microRNAs from the biological sample of the subject suspected of suffering from advanced colorectal adenomas with the overall expression pattern of the one or more microRNAs from a biological sample of a normal subject, wherein the normal subject is a healthy subject not suffering from advanced colorectal adenomas, and wherein overexpression of miR18a is indicative of advanced colorectal adenomas. measuring an overall expression pattern or level of one or more microRNAs obtained from one or more biological samples of the subject, wherein at least one of those microRNAs is miR18a; and comparing the overall expression pattern of the one or more microRNAs from the biological sample of the subject suspected of suffering from advanced colorectal adenomas with the overall expression pattern of the one or more microRNAs from a biological sample of a normal subject, wherein the normal subject is a healthy subject not suffering from advanced colorectal adenomas, and wherein overexpression of miR18a is indicative of advanced colorectal adenomas.
A coating composition comprising a water-thinned isocyanate component A having an isocyanate concentration between 2% by weight and 40% by weight, defined as the proportion by weight of the isocyanate group in the overall molecule that contains at least one hydrophilized polyisocyanate, the isocyanate groups of which are in direct contact with water, wherein the coating composition has a content of polymeric polyols of not more than 10% by weight.
A touch-sensitive display device, comprising: a first panel configured to display information from an electronic device; a transparent second panel detachably securable to the first panel and configured to cover the first panel; at least one ultraviolet or near ultraviolet light unit configured to provide UV light to an edge of the transparent second panel; and a camera mounted behind the first and second panels configured to capture an image of fluorescent markings taken through the first and second panels and made on the transparent second panel. a first panel configured to display information from an electronic device; a transparent second panel detachably securable to the first panel and configured to cover the first panel; at least one ultraviolet or near ultraviolet light unit configured to provide UV light to an edge of the transparent second panel; and a camera mounted behind the first and second panels configured to capture an image of fluorescent markings taken through the first and second panels and made on the transparent second panel.